Clinical Trial Update: Risk of Post Transfusion Hepatitis C Virus Infection

View source ↗

Summary

A completed NHLBI clinical trial assesses the risk of hepatitis C virus infection after blood transfusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hepatitis, Viral, Human, Blood Transfusion | Status: COMPLETED